Goldstone Financial Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$730K Sell
8,626
-418
-5% -$33.7K 0.07% 154
2026
Q1
$640K Sell
9,044
-2,194
-20% -$164K 0.07% 154
2025
Q4
$887K Buy
11,238
+828
+8% +$65.5K 0.1% 120
2025
Q3
$858K Buy
10,410
+1,833
+21% +$144K 0.1% 121
2025
Q2
$692K Buy
8,577
+1,581
+23% +$122K 0.09% 130
2025
Q1
$562K Buy
6,996
+197
+3% +$16.4K 0.09% 125
2024
Q4
$557K Buy
6,799
+898
+15% +$74.7K 0.09% 118
2024
Q3
$487K Buy
5,901
+979
+20% +$73.1K 0.08% 120
2024
Q2
$345K Buy
4,922
+600
+14% +$42.8K 0.07% 132
2024
Q1
$320K Buy
4,322
+181
+4% +$12.6K 0.07% 122
2023
Q4
$274K Sell
4,141
-9
-0.2% -$563 0.07% 131
2023
Q3
$261K Sell
4,150
-462
-10% -$28.8K 0.08% 125
2023
Q2
$261K Buy
4,612
+1,079
+31% +$59.9K 0.08% 141
2023
Q1
$205K Buy
+3,533
New +$238K 0.07% 148

Other funds holding MET

Goldstone Financial Group's MET Position: Q2 2026 in Review

Goldstone Financial Group reduced its MetLife (MET) stake by 4.6% in Q2 2026, selling an estimated $33.7K and leaving 8,626 shares worth $730K. The position accounts for 0.07% of the portfolio, ranked #154.

Goldstone Financial Group first reported a position in MET in Q1 2023 and has held it in 14 quarters since. The position peaked at $887K in Q4 2025. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Goldstone Financial Group held 8,626 shares of MetLife worth $730K as of Q2 2026.
  • Goldstone Financial Group sold 418 MetLife shares in Q2 2026, an estimated $33.7K.
  • MetLife made up 0.07% of Goldstone Financial Group's portfolio in Q2 2026, its #154 holding.
  • Goldstone Financial Group first reported a position in MetLife in Q1 2023 and has held it in 14 quarters since.
  • Goldstone Financial Group's MetLife position peaked at $887K in Q4 2025.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Goldstone Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.